Jin-Hai Tang

miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression.

miR-197: A novel biomarker for cancers.

MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.

MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.

Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.

DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.

The role of circRNAs in cancers.

Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer.

SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway.

Circular RNAs and exosomes in cancer: a mysterious connection.

Exosome-mediated miR-222 transferring: An insight into NF-κB-mediated breast cancer metastasis.

A novel Met-IR-782 near-infrared probe for fluorescent imaging-guided photothermal therapy in breast cancer.

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer.

The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasis.

Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.

Exosome: a novel mediator in drug resistance of cancer cells.

Circular RNA circASS1 is downregulated in breast cancer cells MDA-MB-231 and suppressed invasion and migration.

MiR-101: a potential therapeutic target of cancers.

Clinical and pathological significance of ceramide synthase 2 (CerS-2) in diverse human cancers.

The emerging role of circular RNAs in breast cancer.

Future perspectives of Sleeping Beauty transposon system in cancer research.